Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients

NCT01123655 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

FED

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: APLA12
DRUG: Placebo

Sponsor

VA Office of Research and Development